Lupin Limited — Pyrazinamide Exporter Profile
Indian Pharmaceutical Exporter · #1 for Pyrazinamide · $16.1M export value · DGFT Verified
Lupin Limited is the #1 Indian exporter of Pyrazinamide with $16.1M in export value and 321 verified shipments. Lupin Limited holds a 1.7% market share in Pyrazinamide exports across 49 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Pyrazinamide Export Profile: Buyers & Destinations
Where Does Lupin Limited Export Pyrazinamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $2.8M | 63 | 19.9% |
| PHILIPPINES | $1.7M | 42 | 12.4% |
| NIGERIA | $1.5M | 30 | 10.5% |
| BRAZIL | $1.4M | 29 | 9.7% |
| NETHERLANDS | $1.1M | 23 | 7.5% |
| MYANMAR | $718.6K | 16 | 5.1% |
| INDONESIA | $700.0K | 14 | 5.0% |
| KENYA | $550.4K | 12 | 3.9% |
| ETHIOPIA | $250.0K | 5 | 1.8% |
| MADAGASCAR | $200.0K | 4 | 1.4% |
Lupin Limited exports Pyrazinamide to 50 countries. The largest destination is SOUTH AFRICA accounting for 19.9% of Lupin Limited's Pyrazinamide shipments, followed by PHILIPPINES (12.4%) and NIGERIA (10.5%). These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pyrazinamide from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATIONAL TUBERCULOSIS AND LEPROSY | NIGERIA | $1.2M | 24 |
| UPD LEA GLEN, PHARMA DYNAMICS C/O | SOUTH AFRICA | $1.0M | 22 |
| I+SOLUTIONS | NETHERLANDS | $851.0K | 19 |
| UPD LEA GLEN, | SOUTH AFRICA | $662.2K | 16 |
| LUPIN PHILIPPINES INC | PHILIPPINES | $650.2K | 17 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN P | INDONESIA | $650.0K | 13 |
| MOREIRA AND PINHEIRO TRADING, LDA | BRAZIL | $600.0K | 12 |
| UPD LEA GLEN | SOUTH AFRICA | $584.0K | 13 |
| TO THE ORDER | BRAZIL | $550.0K | 11 |
| LUPIN PHILIPPINES INC. | PHILIPPINES | $450.1K | 11 |
Lupin Limited supplies Pyrazinamide to 93 buyers globally. The largest buyer is NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA), followed by UPD LEA GLEN, PHARMA DYNAMICS C/O (SOUTH AFRICA) and I+SOLUTIONS (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pyrazinamide Export Value and How Much Does Lupin Limited Contribute?
India exported $50.2M worth of Pyrazinamide through 1,459 shipments from 90 suppliers to 131 countries, serving 434 buyers globally. Lupin Limited contributes $16.1M to this total, accounting for 1.7% of India's Pyrazinamide exports. Lupin Limited ships Pyrazinamide to 50 countries through 93 buyers.
What Is the Average Shipment Value for Lupin Limited's Pyrazinamide Exports?
Lupin Limited's average Pyrazinamide shipment value is $50.0K per consignment, based on 321 shipments totaling $16.1M. The largest destination is SOUTH AFRICA (19.9% of Lupin Limited's Pyrazinamide exports).
How Does Lupin Limited Compare to Other Indian Pyrazinamide Exporters?
Lupin Limited ranks #1 among 90 Indian Pyrazinamide exporters with a 1.7% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($18.1M), LUPIN LIMITED ($16.1M), MACLEODS PHARMACEUTICALS LIMITED ($7.2M). Lupin Limited processed 321 shipments to 49 destination countries.
What Pyrazinamide Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 4 FDC TABLET ALU ALU(RF-IH-ET-PY)BRA(RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL HCL 275MG)-1BOXx15x6T | $600.0K | 12 |
| STOP TB CAT I & III PATIENT KIT-A (GDF)RIFAMPICIN 150MG+ ISONIAZIDE 75MG+ PYRAZINAMIDE 400MG+ ETHAMBUTOL 275MG) 6X28TABTBS | $450.0K | 9 |
| STOP TB CAT I & III PATIENT KIT-AGDF RIFAMPICIN 150MG+ISONIAZIDE 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL 275MG | $400.0K | 8 |
| RIFAMPICIN 150MG+ISONIAZIDE 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL 275MG)6X28TAB+RIFAMPICIN 150MG+IS(QTY 5494 BOX ) | $292.1K | 6 |
| 4 FDC TAB ALU ALU 15X6 RF IH ET PY BRARifampin150 MG Isoniazid 75 MG Pyrazinamide 400MG and Ethambutol Hydrochlorid | $250.0K | 5 |
| STOP TB CAT I & III PATIENT KIT-A (GDF)Rifampicin 150mg+ Isoniazide 75mg+ Pyrazinamide 400mg+ Ethambutol*** | $250.0K | 5 |
| 4 FDC - RISOPET 84T (SOUTH AFRICA) RIFAMPIN, ISONIAZID, PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USP ANTITUBERC | $231.1K | 5 |
| 4 FDC RISOPET 56T SOUTH AFRICA RIFAMPIN 150MG ISONIAZID 75MG PYRAZINAMIDE 400MG AND ETHAMBUTOL HYDROCHLORIDE 275MG | $224.4K | 5 |
| QUADMAX 12X14T ALU / ALU PHILIPPINES RIFAMPIN ISONIAZID PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USP | $200.0K | 4 |
| STOP TB CAT I+II KIT ARIFAMPICIN150MG+ISONIAZID75MG+PYRAZINAMIDE400MG+ETHAMBUTOL275MG6x28T+RIFA.150MG+ISO.75MG12x28T | $200.0K | 4 |
Lupin Limited exports 179 distinct Pyrazinamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 4 FDC TABLET ALU ALU(RF-IH-ET-PY)BRA(RIFAMPICIN 150MG+ISONIA with 12 shipments worth $600.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Pyrazinamide to Key Markets
What Lupin Limited must comply with to export Pyrazinamide to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Lupin Limited Compare to Nearest Pyrazinamide Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MACLEODS PHARMACEUTICALS LTD | $18.1M | 361 | 84 | $50.0K |
| 1 | LUPIN LIMITED ★ | $16.1M | 321 | 49 | $50.0K |
| 3 | MACLEODS PHARMACEUTICALS LIMITED | $7.2M | 143 | 51 | $50.0K |
| 4 | MANEESH PHARMACEUTICALS LIMITED | $3.5M | 69 | 24 | $50.0K |
Lupin Limited ranks #1 among 90 Indian Pyrazinamide exporters. Average shipment value of $50.0K compared to the market average of $557.3K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and MACLEODS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Pyrazinamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 357 | 24.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 170 | 11.7% |
| DELHI AIR | 154 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 126 | 8.6% |
| Bombay Air | 94 | 6.4% |
| NHAVA SHEVA SEA (INNSA1) | 87 | 6.0% |
| JNPT | 87 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 81 | 5.6% |
What Other Tuberculosis Medications Products Does Lupin Limited Export?
Lupin Limited also exports these tuberculosis medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Lupin Limited's Pyrazinamide Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Pyrazinamide, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pyrazinamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pyrazinamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 321 individual customs records matching Lupin Limited exporting Pyrazinamide, covering 179 formulations to 50 countries via 93 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 434+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pyrazinamide Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Pyrazinamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Pyrazinamide Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pyrazinamide. For current shipment-level data, contact TransData Nexus.